Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A JONES

Showing results (211-220 of 212) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 212 results.
Leukemia|October 8, 2015
Incidence and description of autoimmune cytopenias during treatment with ibrutinib for chronic lymphocytic leukemiaK A Rogers, A S Ruppert, A Bingman, et al.
Leukemia|January 22, 2014
The CD37-targeted antibody-drug conjugate IMGN529 is highly active against human CLL and in a novel CD37 transgenic murine leukemia modelK A Beckwith, F W Frissora, M R Stefanovski, et al.
Pageof 22

Showing results (211-220 of 212) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 212 results.
Leukemia|October 8, 2015
Incidence and description of autoimmune cytopenias during treatment with ibrutinib for chronic lymphocytic leukemiaK A Rogers, A S Ruppert, A Bingman, et al.
Leukemia|January 22, 2014
The CD37-targeted antibody-drug conjugate IMGN529 is highly active against human CLL and in a novel CD37 transgenic murine leukemia modelK A Beckwith, F W Frissora, M R Stefanovski, et al.
Pageof 22